The United States Department of Agriculture has issued interim rules governing the commercial cultivation of hemp. The rules are still subject to a mandatory 60-day public comment period following their publication in the Federal Register.
According to the report, “The number of acres of hemp licensed across 34 states totaled 511,442 in 2019 – more than quadruple the number of acres licensed from the previous year.”
A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators.
Members of the US Senate Committee on Agriculture, Nutrition, and Forestry will hear expert testimony next week regarding the production of industrial hemp and hemp-derived products.
NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. The agency will be taking in person public testimony on Friday, May 31, with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products.
Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado.
State lawmakers have approved a series of bills reducing penalties for marijuana possession offenses and strengthening and expanding legal protections for medical cannabis patients.
In New Hampshire, there has been a great deal of progress in the last few years. Several bills have been introduced in the state legislature, ranging from legal hemp production to adult-use marijuana legalization, and the fight for freedom has never been more widely supported than now.